rs1538240
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_052867.4(NALCN):c.800-23593A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.471 in 151,810 control chromosomes in the GnomAD database, including 17,191 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.47 ( 17191 hom., cov: 30)
Consequence
NALCN
NM_052867.4 intron
NM_052867.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0890
Publications
2 publications found
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
- congenital contractures of the limbs and face, hypotonia, and developmental delayInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- hypotonia, infantile, with psychomotor retardation and characteristic facies 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- digitotalar dysmorphismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Freeman-Sheldon syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Sheldon-hall syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypotonia, infantile, with psychomotor retardation and characteristic faciesInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- temporal lobe epilepsyInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.66 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NALCN | NM_052867.4 | c.800-23593A>G | intron_variant | Intron 7 of 43 | ENST00000251127.11 | NP_443099.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.471 AC: 71478AN: 151692Hom.: 17175 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
71478
AN:
151692
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.471 AC: 71536AN: 151810Hom.: 17191 Cov.: 30 AF XY: 0.477 AC XY: 35417AN XY: 74200 show subpopulations
GnomAD4 genome
AF:
AC:
71536
AN:
151810
Hom.:
Cov.:
30
AF XY:
AC XY:
35417
AN XY:
74200
show subpopulations
African (AFR)
AF:
AC:
15903
AN:
41394
American (AMR)
AF:
AC:
7905
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
1817
AN:
3464
East Asian (EAS)
AF:
AC:
3478
AN:
5120
South Asian (SAS)
AF:
AC:
2447
AN:
4804
European-Finnish (FIN)
AF:
AC:
5778
AN:
10552
Middle Eastern (MID)
AF:
AC:
129
AN:
294
European-Non Finnish (NFE)
AF:
AC:
32531
AN:
67916
Other (OTH)
AF:
AC:
1018
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1841
3682
5523
7364
9205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2012
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.